Professor of Medicine and a Scientist with the Broad Stem Cell Research Center, UCLA
Professor of Medicine and a Scientist with the Broad Stem Cell Research Center, UCLA
PROFILE
Dr. Antoni Ribas
Guest
FROM Dr. Antoni Ribas
Which Way, L.A.?
Big Stem Cell Grants California’s Institute for Regenerative Medicine is a unique state agency—with guaranteed funding of 3 billion dollars from bonds. It was created by the voters in 2004, when the Bush Administration opposed using embryonic stem cells for medical research. The promise was to develop treatments for incurable diseases but—whatever the voters thought 8 years ago—that takes a long time. Last week, the Institute passed out its latest grants—150 million dollars, in hopes of moving from laboratories into clinical trials. UCLA’s Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research got 20 million dollars last week from the Institute.
Recommended
To the Point
Who's to blame for the opioid crisis? Some of the lawyers who took on Big Tobacco are now going after Big Pharma. It’s all about the deadly epidemic of opioid use. Are the drug companies to blame? What about the users? Later, on today’s Talking Point: making sense of Britain’s upset election.
To the Point
Venezuela spirals into economic and political chaos Venezuela, a country whose potential for prosperity is unmatched, finds itself on the verge of civil war. What sustains the repressive government? With time running out, guest host León Krauze looks at what the international community can do to pull the country from the edge of collapse.
To the Point
Will the Senate write a healthcare bill in secret? While Democrats and Republicans argue White House relations with Russia, another question is being decided behind closed doors: who gets help buying health insurance and who doesn't? We hear how the pros and cons are being shrouded in secrecy.
To the Point
Replacing Obamacare: Now you see it… now you don’t As the Senate deliberates replacing Obmacare, health coverage for millions of people is at stake. There've been no public hearings, and a draft measure won't be made public. Is the House version so unpopular that that Senate is hiding a version that looks much the same?